Search

Changes to Formulary as of 22nd November 2017:

BNF Category Number

Product/indication

Detail of change

6.1.1.2

Insulin Deguldec 100u/ml

Added as Green+ for use in paediatric type 1 diabetics

4.2.2

Paliperidone depot injection

Added link to Sept 2017 NTAG guidance

4.5.1

Liraglutide

Changed from NOT REVIEWED to NOT APPROVED and added link to Sept 2017 NTAG Guidance

9.1.3 a

Darbepoetin alfa 

Changed from AMBER to RED

9.1.3 a

Epoetin alfa 

Changed from AMBER to RED

9.1.3 a

Epoetin beta

Changed from AMBER to RED

3.4.1

Alimemazine

Changed from GREEN to RED

11.6

Xalacom® eye drops

Changed to listing generically

11.3.1

Polyhexamethylene biguinide (PHMB) 0.02% eye drops

Added as RED drug

8.1.5

Cabozantinib

Added as a RED drug and added link to NICE TA463

6.6.2.2

Bisphosphonates (IV and oral)

Added link to NICE TA464

8.1.5

Olaratumab

Added as a RED drug and added link to NICE TA465

11.8

Holoclar

Added as a RED drug and added link to NICE TA467

10.1.3

Baricitinib

Added as a RED drug and added link to NICE TA466

1.4.2

Eluxadoline

Changed from NOT APPROVED to Green+ and added link to NICE TA471

8.2.3

Obinutuzumab

Added link to NICE TA472

8.1.5

Cetuximab

Added link to NICE TA473

8.1.5

Sorafenib

Added link to NICE TA474

13.5.2

Dimethyl fumarate

Added link to NICE TA475 and changed product from unlicensed to licensed

8.1.5

Paclitaxel albumin

Added link to NICE TA476

8.1.5

Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia; risk of hepatitis B reactivation and of opportunistic infections

Added link to MHRA DSU guidance

6.3

Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration

Added link to MHRA DSU guidance

3.4.3.1

Adrenaline auto-injectors: updated advice after European review

Added link to MHRA DSU guidance

12.3.2

Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin

Added link to MHRA DSU guidance

1.4.2

Loperamide (Imodium): reports of serious cardiac adverse reactions with high doses of loperamide associated with abuse or misuse

Added link to MHRA DSU guidance

4.5.1

Decapeptyl SR (Triptorelin) 11.25 mg: change in salt

Added link to MHRA DSU guidance

1.5.3, 10.1.3, 13.5.3

DMARDs

Added links to updated shared care guidelines

4.9.1

Apomorphine

Added link to updated shared care guidelines

4 and 4.7

Introduction and Analgesic section

Added link to pain guidelines